Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
NANOMIX CorpListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GALECTIN THERAPEUTICS INCListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PHARMOS CORPListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GALECTIN THERAPEUTICS INCListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PHARMOS CORPListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GALECTIN THERAPEUTICS INCListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GALECTIN THERAPEUTICS INCListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GALECTIN THERAPEUTICS INCListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PHARMOS CORPListing unverified | Award | $26.3K | SEC | ||
PHARMOS CORPListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GT Biopharma, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PHARMOS CORPListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GT Biopharma, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PHARMOS CORPListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
HORIZON PHARMACEUTICAL LLCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GT Biopharma, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GT Biopharma, Inc.Listing on record | AwardD (derivative) | $29K | SEC | ||
HORIZON PHARMACEUTICAL LLCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GT Biopharma, Inc.Listing on record | AwardD (derivative) | $1.7K | SEC | ||
HORIZON PHARMACEUTICAL LLCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
HORIZON PHARMACEUTICAL LLCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GT Biopharma, Inc.Listing on record | AwardD (derivative) | $59K | SEC | ||
GT Biopharma, Inc.Listing on record | AwardD (derivative) | $20.7K | SEC | ||
HORIZON PHARMACEUTICAL LLCListing unverified | AwardD (derivative) | $36.1K | SEC | ||
HORIZON PHARMACEUTICAL LLCListing unverified | AwardD (derivative) | $352K | SEC |